NDC 29300-353 – Doxazosin Mesylate

Doxazosin Mesylate 4 mg/1 · Tablet · Oral

Human Prescription Drug 1 recall

Product NDC29300-353

Product details

Brand name
Doxazosin Mesylate
Generic name
Doxazosin Mesylate
Labeler
Unichem Pharmaceuticals (USA), Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA212329
Marketed since
January 10, 2024
Listing expires
December 31, 2026
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Doxazosin mesylate →

Package NDC codes (3)

Package NDCDescriptionSince
29300-353-01100 TABLET in 1 BOTTLE (29300-353-01)Mar 15, 2024
29300-353-101000 TABLET in 1 BOTTLE (29300-353-10)Mar 15, 2024
29300-353-1330 TABLET in 1 BOTTLE (29300-353-13)Mar 15, 2024

Recalls mentioning this NDC

Other Doxazosin mesylate products